TrialFrontiers in endocrinology2024

Efficacy and safety of polyethylene glycol loxenatide in treating mild-to-moderate diabetic kidney disease in type 2 diabetes patients: a randomized, open-label, clinical trial.

YongSheng Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.